Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fosfomycin vs meropenem for ESBL E. coli bacteremic urinary tract infection
2013-002922-21Phase 3Completed
- Sponsor
- Fundación Pública Andaluza para la Gestión de la Investigación
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in urinary tract infection (UTI) and Escherichia coli bacteremia comparing Fosfomycin with Meropenem (2 arms). Primary endpoint: Clinical and microbiological cure at test-of-cure visit. Started Feb 2014; status: completed.
02
Drugs
fosfomycinmeropenem
03
Conditions
urinary tract infection (UTI)Escherichia coli bacteremia
Beyond the preview
Go deeper on 2013-002922-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002922-21.